The leading market experts have placed a mean price target of $26.360 on Qiagen N.V. (NASDAQ:QGEN) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.390 a share for the upcoming quarter and $1.090 for the current fiscal.
The technical analysis of Qiagen N.V. plainly substantiates that the 50-day moving average of Qiagen N.V. is $25.542, and stock is trading $0.853 points away or +3.340% from its 50-day moving average of $25.542. Further it is trading $3.509 or +15.333% away its 200-day moving average of $22.886. Qiagen N.V. (NASDAQ:QGEN) 52-week high is $28.530 and the 52-week low is $19.940.
This explains if the stock moves $-2.135, it will post a 52-week high. In event of +32.372% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Qiagen N.V., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Qiagen N.V. (NASDAQ:QGEN) ratio came in at 52.790.
The stock last ended the trading session at $26.395 and registered a market cap of $6.18B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Qiagen N.V. (NASDAQ:QGEN) PEG ratio is at 2.510.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...